Health
Molecular imaging can predict response to novel metastatic breast cancer treatment – News-Medical.Net
Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal…
Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of the Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy.
Nearly two-thirds of…
-
Noosa News14 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News20 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business19 hours agoAre BHP shares are buy after its results?
-
General23 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply